Please login to the form below

Janus kinase inhibitors are amongst the most read abstracts at the American College of Rheumatology 2015

Rheumatologists eagerly await trial data for Janus kinase inhibitors

Data presented during ACR 2015 highlighted the potential impact the Janus kinase inhibitors (JAKi) will bring to optimising treatment for rheumatoid arthritis patients. Read more here http://goo.gl/djQAML

19th November 2015

Share